DEFA14A: Ingevity Responds to Vision One's Presentation, Highlights Performance and Strategic Initiatives

Ingevity addresses Vision One's concerns, emphasizing its strategic initiatives, record performance in Performance Materials, and ongoing portfolio review.

Summary

• Ingevity Corporation issued a letter to stockholders in response to a presentation by Vision One Management Partners.
• The company highlighted its record performance in Performance Materials in 2024, with sales and EBITDA margins surpassing 50%.
• Ingevity is transforming its Performance Chemicals segment by exiting lower margin markets and optimizing costs, resulting in $84 million in savings in 2024, exceeding the target of $65-$75 million.
• The company is reviewing its portfolio, including a formal process for the Industrial Specialties product line and the North Charleston CTO refinery, with a path forward expected by year-end.
• Ingevity added J. Kevin Willis to its Board in December 2024, as part of its ongoing board refreshment process.
• The company's second half EBITDA margins increased to approximately 28% in 2024, and it delivered free cash flow that significantly exceeded prior guidance.
• Ingevity is targeting a net leverage ratio of below 2.8x by year-end 2025 and expects $400 to $415 million in EBITDA in 2025.
• Vision One nominated four director candidates, but Ingevity's Nominating and Governance Committee did not recommend any of them.
• Ingevity offered to work collaboratively with Vision One to identify a mutually agreed director candidate but Vision One rejected the offer and launched a proxy contest.
• Ingevity intends to file a proxy statement with the SEC in connection with the solicitation of proxies for its 2025 annual meeting of stockholders.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting strong performance in key segments and strategic initiatives. However, the proxy contest initiated by Vision One introduces some uncertainty.

Positives

• Record performance in Performance Materials with margins surpassing 50%.
• Significant savings achieved through Performance Chemicals repositioning actions, exceeding targets.
• Improved EBITDA margins and free cash flow.
• Targeted reduction in net leverage ratio.
• Ongoing review of the business portfolio to focus on higher growth opportunities.
• Addition of a new independent director with relevant experience.

Negatives

• Vision One's rejection of Ingevity's offer to collaborate on director selection.
• Vision One's launch of a proxy contest.
• The company is in the midst of a CEO transition.

Risks

• Potential disruption from the proxy contest initiated by Vision One.
• Uncertainty related to the CEO transition.
• Risks associated with the strategic review of the Industrial Specialties product line and North Charleston CTO refinery.
• Dependence on the cyclical automotive market and potential adverse conditions in that market.
• Risks related to international sales and operations, including geopolitical and financial conditions.

Future Outlook

Ingevity expects to continue its strong trajectory in 2025, targeting $400 to $415 million in EBITDA and a net leverage ratio of below 2.8x by year-end 2025.

Management Comments

• The Ingevity Board of Directors and leadership team are committed to taking aggressive actions to deliver significant, sustainable value creation for all Ingevity stockholders.
• We are proceeding expeditiously with the review of Industrial Specialties and the refinery and expect to communicate a path forward by year end.
• The CEO search is progressing well and we are very pleased with the quality of the candidates under consideration.
• We firmly believe that Ingevitys premier activated carbon platform, leading specialty chemicals business, global footprint and talented employees provide a strong foundation for profitable growth.

Industry Context

Ingevity's focus on Performance Materials aligns with the trend of increasing fuel efficiency in ICE vehicles and the growing popularity of hybrids. The company's investment in silicon anode batteries through Nexeon positions it to capitalize on the expanding market for electric vehicle batteries. The strategic review of the Industrial Specialties product line and North Charleston CTO refinery reflects a broader industry trend of companies optimizing their portfolios to focus on higher-growth, higher-margin opportunities.

Comparison to Industry Standards

• Ingevity's Performance Materials segment's EBITDA margins exceeding 50% in 2024 are strong compared to specialty chemical companies like Ashland, which reported adjusted EBITDA margins of around 18% in its most recent quarter.
• The targeted net leverage ratio of below 2.8x by year-end 2025 is a reasonable goal compared to companies like Celanese, which has a stated goal of maintaining investment grade credit ratings and a leverage ratio between 2.0x and 3.0x.
• The strategic review of the Industrial Specialties product line and North Charleston CTO refinery is similar to actions taken by companies like DuPont, which has been actively divesting non-core assets to focus on its core businesses.

Stakeholder Impact

• Shareholders: The company is focused on delivering significant, sustainable value creation.
• Employees: The company emphasizes that it is business as usual and that the news has no impact on strategic objectives or daily operations.
• Customers: The company is committed to providing products and technologies that purify, protect, and enhance the world around us.

Next Steps

• Ingevity will communicate a path forward regarding the review of Industrial Specialties and the refinery by year-end.
• The company will file a proxy statement with the SEC in connection with the solicitation of proxies for its 2025 annual meeting of stockholders.
• Ingevity will engage with stockholders to hear their perspectives on the proxy contest.

Key Dates

Keywords

Ingevity, Vision One, Proxy Contest, Performance Materials, Performance Chemicals, Strategic Review, Board of Directors, EBITDA, Leverage Ratio, Industrial Specialties